Patents by Inventor Abderrahim Bouzide

Abderrahim Bouzide has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060183800
    Abstract: Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease. Also described are methods, compounds, pharmaceutical compositions and kits for detecting, diagnosing, monitoring and treating or preventing amyloid-related disease.
    Type: Application
    Filed: November 14, 2005
    Publication date: August 17, 2006
    Inventors: Xianqi Kong, Xinfu Wu, Abderrahim Bouzide, Isabelle Valade, David Migneault, Francesco Bellini
  • Patent number: 6677367
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: January 13, 2004
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6656965
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: December 2, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030195159
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: October 24, 2002
    Publication date: October 16, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6610689
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 26, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6608100
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 19, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030144265
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: September 17, 2002
    Publication date: July 31, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030119803
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: September 17, 2002
    Publication date: June 26, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6528532
    Abstract: The present invention provides HIV aspartyl protease inhibitors of the formula: and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein n is 3 or 4, Y is O, S, NH or N—CN, wherein Cx may be, for example COOH, or CH2OH, wherein R1 is selected from the group consisting of a benzenesulfonyl group of formula II as defined herein, wherein R2 may be, for example, iso-butyl, or 3-methylbutyl, and wherein R3 and R4 are as defined herein.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: March 4, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Abderrahim Bouzide, Gilles Sauvé
  • Patent number: 6506786
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: January 14, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20020151546
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: February 13, 2001
    Publication date: October 17, 2002
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6455587
    Abstract: The present invention relates to a class of amino acid derivatives with HIV aspartyl protease inhibitory properties.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: September 24, 2002
    Assignee: Pharmacor Inc.
    Inventors: Abderrahim Bouzide, Gilles Sauvé, Brent Richard Stranix, Guy Sévigny, Jocelyn Yelle
  • Patent number: 6313177
    Abstract: A D-mannitol derivative selected from the group consisting of a compound of formula pharmaceutically acceptable derivatives thereof and where applicable or appropriate pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are the same or different and may each independently be selected from among alkyl and aryl (i.e. aromatic including aromatic like) groups. The D-mannitol derivatives may be used as HIV aspartyl protease inhibitors.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: November 6, 2001
    Assignee: Pharmacor Inc.
    Inventors: Gilles Sauvé, Abderrahim Bouzide